Urinary Tract Infections in Children: Changing Trends in Etiology and Local Resistance Patterns over a Three-Year Period
Main Author: | |
---|---|
Publication Date: | 2025 |
Other Authors: | , , , , |
Format: | Article |
Language: | eng |
Source: | Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) |
Download full: | https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/21630 |
Summary: | Introduction: Urinary tract infections are common in pediatrics. Knowledge of local resistance patterns is crucial to guide empirical antibiotic therapy. We aimed to review the pathogens implicated in urinary tract infections, local resistance patterns, and the impact of switching first-line empirical antibiotic regimens.Methods: We conducted a cross-sectional study including pediatric patients performing urine cultures in a hospital in northern Portugal over two periods: 2019 (group 1) and 2022 (group 2). Between time periods, an internal guideline was implemented recommending cefuroxime as the first-line choice for empirical treatment of urinary tract infections, according to local resistance patterns. Uropathogens, empirical antibiotic choices and resistance patterns were compared among groups.Results: The final sample included 402 cases of urinary tract infections in group 1 and 398 in group 2. Escherichia coli was the most common uropathogen (79.4 - 83.3%), followed by Proteus mirabilis and Klebsiella spp. The most common empirical antibiotic in group 1 was amoxicillin-clavulanate (A-C), as opposed to cefuroxime in group 2 (p < 0.001). The most common resistance was to ampicillin (39.3% - 39.7%). Resistance to A-C slightly decreased (33.1% vs 27.4%, p = 0.079), while resistance to cefuroxime (4.7% vs 3.3%, p = 0.292) and trimethoprim-sulfamethoxazole (TMP-SMX) remained similar (15.2% vs 14.1%, p = 0.659). Resistances to nitrofurantoin (9.0% vs 0.3%, p < 0.001) and fosfomycin (1.7% vs 0.3%, p < 0.036) significantly decreased from group 1 to group 2.Conclusion: E.coli remains the predominant pathogen in pediatric urinary tract infections. Resistance to A-C in our sample was high (33.1%). The switch from A-C to cefuroxime as first-line agent resulted in a decreasing trend in A-C resistance, while cefuroxime resistance remained low and even slightly lower. |
id |
RCAP_b8a9c30132676d08855aa9056579adb5 |
---|---|
oai_identifier_str |
oai:ojs.www.actamedicaportuguesa.com:article/21630 |
network_acronym_str |
RCAP |
network_name_str |
Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) |
repository_id_str |
https://opendoar.ac.uk/repository/7160 |
spelling |
Urinary Tract Infections in Children: Changing Trends in Etiology and Local Resistance Patterns over a Three-Year PeriodInfeções do Trato Urinário em Pediatria: Evolução da Etiologia e Padrões de Resistências Locais ao Longo de Três AnosChildDrug Resistance, BacterialUrinary Tract Infections/drug therapyUrinary Tract Infections/etiologyUrinary Tract Infections/microbiologyCriançaInfeções do Trato Urinário/etiologiaInfeções do Trato Urinário/microbiologiaInfeções do Trato Urinário/tratamento farmacológicoResistência Bacteriana a MedicamentosIntroduction: Urinary tract infections are common in pediatrics. Knowledge of local resistance patterns is crucial to guide empirical antibiotic therapy. We aimed to review the pathogens implicated in urinary tract infections, local resistance patterns, and the impact of switching first-line empirical antibiotic regimens.Methods: We conducted a cross-sectional study including pediatric patients performing urine cultures in a hospital in northern Portugal over two periods: 2019 (group 1) and 2022 (group 2). Between time periods, an internal guideline was implemented recommending cefuroxime as the first-line choice for empirical treatment of urinary tract infections, according to local resistance patterns. Uropathogens, empirical antibiotic choices and resistance patterns were compared among groups.Results: The final sample included 402 cases of urinary tract infections in group 1 and 398 in group 2. Escherichia coli was the most common uropathogen (79.4 - 83.3%), followed by Proteus mirabilis and Klebsiella spp. The most common empirical antibiotic in group 1 was amoxicillin-clavulanate (A-C), as opposed to cefuroxime in group 2 (p < 0.001). The most common resistance was to ampicillin (39.3% - 39.7%). Resistance to A-C slightly decreased (33.1% vs 27.4%, p = 0.079), while resistance to cefuroxime (4.7% vs 3.3%, p = 0.292) and trimethoprim-sulfamethoxazole (TMP-SMX) remained similar (15.2% vs 14.1%, p = 0.659). Resistances to nitrofurantoin (9.0% vs 0.3%, p < 0.001) and fosfomycin (1.7% vs 0.3%, p < 0.036) significantly decreased from group 1 to group 2.Conclusion: E.coli remains the predominant pathogen in pediatric urinary tract infections. Resistance to A-C in our sample was high (33.1%). The switch from A-C to cefuroxime as first-line agent resulted in a decreasing trend in A-C resistance, while cefuroxime resistance remained low and even slightly lower.Introdução: As infeções do trato urinário são comuns em idade pediátrica. Conhecer a etiologia e os padrões de resistência locais é fundamental na determinação do tratamento empírico. Propusemo-nos a rever os patógenos implicados nas infeções do trato urinário, os padrões de resistência locais e o impacto do ajuste da antibioterapia de primeira-linha de acordo com as mesmas. Métodos: Conduzimos um estudo transversal que incluiu os doentes pediátricos que realizaram urocultura num hospital do Norte de Portugal durante dois períodos: 2019 (grupo 1) e 2022 (grupo 2). Entre estes dois períodos, foi instituído um protocolo interno de atuação clínica que recomendava a utilização de cefuroxima como antibioterapia empírica de primeira linha, de acordo com a epidemiologia local. Os grupos foram comparados quanto aos uropatógenos identificados, respetivos padrões de resistência a antimicrobianos e antibioterapia empírica instituída.Resultados: Foram identificados 402 casos de infeções do trato urinário no grupo 1 e 398 no grupo 2. A Escherichia coli (E. coli) foi o uropatógeno mais comum (79,4% - 83,3%), seguido do Proteus mirabilis e da Klebsiella spp. No grupo 1, o antimicrobiano empírico mais frequentemente selecionado foi a amoxicillina-clavulanato (A-C), enquanto no grupo 2 foi a cefuroxima (p < 0.001). A resistência mais frequentemente identificada foi à ampicilina (39.3% - 39.7%). A resistência a A-C não mostrou alterações estatisticamente significativas entre grupos (33,1% vs 27,4%, p = 0,079), tal como a resistência à cefuroxima (4,7% vs 3,3%, p = 0,292) e ao trimetoprim-sulfametoxazol (TMP-SMX) (15,2% vs 14,1%, p = 0,659). As resistências à nitrofurantoína (9,0% vs 0,3%, p < 0.001) e à fosfomicina (1,7% vs 0,3%, p < 0,036) diminuíram significativamente entre o grupo 1 e o grupo 2.Conclusão: A E.coli mantém-se como o principal agente de infeções do trato urinário em pediatria. A resistência a A-C na nossa amostra é elevada (33,1%). A alteração de antibioterapia empírica de primeira-linha de A-C para cefuroxima resultou numa tendência de diminuição da resistência à A-C, sem aumento da resistência a cefuroxima.Ordem dos Médicos2025-02-03info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/21630Acta Médica Portuguesa; Vol. 38 No. 2 (2025): February; 79-87Acta Médica Portuguesa; Vol. 38 N.º 2 (2025): Fevereiro; 79-871646-07580870-399Xreponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiainstacron:RCAAPenghttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/21630https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/21630/15597Direitos de Autor (c) 2025 Acta Médica Portuguesainfo:eu-repo/semantics/openAccessSousa, PatríciaDelgado, LucindaCorreia-de-Oliveira, SusanaPereira, CecíliaDias, ÂngelaTavares, Ana Cláudia2025-02-09T03:00:52Zoai:ojs.www.actamedicaportuguesa.com:article/21630Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireinfo@rcaap.ptopendoar:https://opendoar.ac.uk/repository/71602025-05-28T19:46:42.311988Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiafalse |
dc.title.none.fl_str_mv |
Urinary Tract Infections in Children: Changing Trends in Etiology and Local Resistance Patterns over a Three-Year Period Infeções do Trato Urinário em Pediatria: Evolução da Etiologia e Padrões de Resistências Locais ao Longo de Três Anos |
title |
Urinary Tract Infections in Children: Changing Trends in Etiology and Local Resistance Patterns over a Three-Year Period |
spellingShingle |
Urinary Tract Infections in Children: Changing Trends in Etiology and Local Resistance Patterns over a Three-Year Period Sousa, Patrícia Child Drug Resistance, Bacterial Urinary Tract Infections/drug therapy Urinary Tract Infections/etiology Urinary Tract Infections/microbiology Criança Infeções do Trato Urinário/etiologia Infeções do Trato Urinário/microbiologia Infeções do Trato Urinário/tratamento farmacológico Resistência Bacteriana a Medicamentos |
title_short |
Urinary Tract Infections in Children: Changing Trends in Etiology and Local Resistance Patterns over a Three-Year Period |
title_full |
Urinary Tract Infections in Children: Changing Trends in Etiology and Local Resistance Patterns over a Three-Year Period |
title_fullStr |
Urinary Tract Infections in Children: Changing Trends in Etiology and Local Resistance Patterns over a Three-Year Period |
title_full_unstemmed |
Urinary Tract Infections in Children: Changing Trends in Etiology and Local Resistance Patterns over a Three-Year Period |
title_sort |
Urinary Tract Infections in Children: Changing Trends in Etiology and Local Resistance Patterns over a Three-Year Period |
author |
Sousa, Patrícia |
author_facet |
Sousa, Patrícia Delgado, Lucinda Correia-de-Oliveira, Susana Pereira, Cecília Dias, Ângela Tavares, Ana Cláudia |
author_role |
author |
author2 |
Delgado, Lucinda Correia-de-Oliveira, Susana Pereira, Cecília Dias, Ângela Tavares, Ana Cláudia |
author2_role |
author author author author author |
dc.contributor.author.fl_str_mv |
Sousa, Patrícia Delgado, Lucinda Correia-de-Oliveira, Susana Pereira, Cecília Dias, Ângela Tavares, Ana Cláudia |
dc.subject.por.fl_str_mv |
Child Drug Resistance, Bacterial Urinary Tract Infections/drug therapy Urinary Tract Infections/etiology Urinary Tract Infections/microbiology Criança Infeções do Trato Urinário/etiologia Infeções do Trato Urinário/microbiologia Infeções do Trato Urinário/tratamento farmacológico Resistência Bacteriana a Medicamentos |
topic |
Child Drug Resistance, Bacterial Urinary Tract Infections/drug therapy Urinary Tract Infections/etiology Urinary Tract Infections/microbiology Criança Infeções do Trato Urinário/etiologia Infeções do Trato Urinário/microbiologia Infeções do Trato Urinário/tratamento farmacológico Resistência Bacteriana a Medicamentos |
description |
Introduction: Urinary tract infections are common in pediatrics. Knowledge of local resistance patterns is crucial to guide empirical antibiotic therapy. We aimed to review the pathogens implicated in urinary tract infections, local resistance patterns, and the impact of switching first-line empirical antibiotic regimens.Methods: We conducted a cross-sectional study including pediatric patients performing urine cultures in a hospital in northern Portugal over two periods: 2019 (group 1) and 2022 (group 2). Between time periods, an internal guideline was implemented recommending cefuroxime as the first-line choice for empirical treatment of urinary tract infections, according to local resistance patterns. Uropathogens, empirical antibiotic choices and resistance patterns were compared among groups.Results: The final sample included 402 cases of urinary tract infections in group 1 and 398 in group 2. Escherichia coli was the most common uropathogen (79.4 - 83.3%), followed by Proteus mirabilis and Klebsiella spp. The most common empirical antibiotic in group 1 was amoxicillin-clavulanate (A-C), as opposed to cefuroxime in group 2 (p < 0.001). The most common resistance was to ampicillin (39.3% - 39.7%). Resistance to A-C slightly decreased (33.1% vs 27.4%, p = 0.079), while resistance to cefuroxime (4.7% vs 3.3%, p = 0.292) and trimethoprim-sulfamethoxazole (TMP-SMX) remained similar (15.2% vs 14.1%, p = 0.659). Resistances to nitrofurantoin (9.0% vs 0.3%, p < 0.001) and fosfomycin (1.7% vs 0.3%, p < 0.036) significantly decreased from group 1 to group 2.Conclusion: E.coli remains the predominant pathogen in pediatric urinary tract infections. Resistance to A-C in our sample was high (33.1%). The switch from A-C to cefuroxime as first-line agent resulted in a decreasing trend in A-C resistance, while cefuroxime resistance remained low and even slightly lower. |
publishDate |
2025 |
dc.date.none.fl_str_mv |
2025-02-03 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/21630 |
url |
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/21630 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/21630 https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/21630/15597 |
dc.rights.driver.fl_str_mv |
Direitos de Autor (c) 2025 Acta Médica Portuguesa info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Direitos de Autor (c) 2025 Acta Médica Portuguesa |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Ordem dos Médicos |
publisher.none.fl_str_mv |
Ordem dos Médicos |
dc.source.none.fl_str_mv |
Acta Médica Portuguesa; Vol. 38 No. 2 (2025): February; 79-87 Acta Médica Portuguesa; Vol. 38 N.º 2 (2025): Fevereiro; 79-87 1646-0758 0870-399X reponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia instacron:RCAAP |
instname_str |
FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) |
collection |
Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) |
repository.name.fl_str_mv |
Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia |
repository.mail.fl_str_mv |
info@rcaap.pt |
_version_ |
1833598319747661824 |